Acyclovir is acyclic purine nucleoside analogue active against
herpes simplex virus, varicella zoster, Epstein-Barr virus and cytomegalovirus.
In the cell, undergo phosphorylation acyclovir acyclovir triphosphate into an
active form that inhibit the herpes simplex virus DNA polymerase and viral DNA
replication, thereby preventing viral DNA synthesis without affecting normal
cell processes.
Acyclovir Pharmacology
Acyclovir is an antiviral agent highly active in vitro against herpes simplex virus (HSV) types I and II, and varicella zoster virus. Upon entry into the infected cell, the phosphorylated form of the active compound Acyclovir Acyclovir trifosfate. The initial phase of the process depends on the enzyme thymidine kinase viral-coded. Acyclovir trifosfate act as inhibitors and as a false substrate for the herpes-specified DNA polymerase which prevents viral DNA synthesis without affecting normal cellular processes.
Treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes / recurrent, herpes zoster (shingles / shingles / shingles). Preventing recurrence of herpes simplex infections in patients with strong immune systems. Preventing herpes simplex infection in patients with poor immune systems.
Acyclovir Pharmacology
Acyclovir is an antiviral agent highly active in vitro against herpes simplex virus (HSV) types I and II, and varicella zoster virus. Upon entry into the infected cell, the phosphorylated form of the active compound Acyclovir Acyclovir trifosfate. The initial phase of the process depends on the enzyme thymidine kinase viral-coded. Acyclovir trifosfate act as inhibitors and as a false substrate for the herpes-specified DNA polymerase which prevents viral DNA synthesis without affecting normal cellular processes.
Treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes / recurrent, herpes zoster (shingles / shingles / shingles). Preventing recurrence of herpes simplex infections in patients with strong immune systems. Preventing herpes simplex infection in patients with poor immune systems.